Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elbow fracture showdown: surgery or a simple cast for seniors?

NCT ID NCT07400692

Disease control Sponsor: Ente Ospedaliero Cantonale, Bellinzona Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 10, 2026 · Updated 4 times

Summary

This study compares two ways to treat a broken elbow (olecranon fracture) in people over 65 who don't use their arms heavily. Half will get surgery with a metal plate and screws, and the other half will get a cast or splint. Researchers will measure elbow function, pain, and quality of life over time to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgery (open reduction and plate osteosynthesis) vs. conservative treatment (cast or splint)
What this could lead to
If it works, this could show that a cast is just as good as surgery for certain elbow fractures in older adults, avoiding the risks of an operation.
What could go wrong
This is a small, single-hospital trial with only 84 participants, so results may not apply to everyone. The study is still recruiting, and it's too early to know which treatment is better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Patients with an acute (\< 2 weeks) Mayo type 2A or 2B olecranon fracture * Patients aged \> 65 years • Patients with reduced functional demand, with a score \> 2 and \< 7 on the Clinical Frailty Scale * Patients able to provide informed consent and follow all study procedures as indicated in the protocol * Signed informed consent for study participation Exclusion criteria: * Patients aged \< 65 years or with a Clinical Frailty Scale score \> 7 or \< 2 * Patients with a Mayo type 2A or 2B fracture seen more than 2 weeks after injury * Old fracture (\> 6 months), pseudoarthrosis, or unhealed nerve injury of the ipsilateral upper limb * Open (Gustilo-Anderson type 2 or 3) or pathological fracture * Previous injury to, or other condition of, the elbow with severe functional impairment * Patients with severe comorbidities preventing safe surgical treatment * Other acute fracture or nerve damage of the ipsilateral upper limb * Known drug or alcohol abuse * Inability to follow study procedures (e.g., due to language barriers or severe comorbidities)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Olecranon fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Olecranon Fracture ulna fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Olecranon fracture

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • EOC - Orthopaedics and Traumatology Service

    RECRUITING

    Lugano, 6900, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.